Skip to main content
. 2015 May 15;10(5):e0126153. doi: 10.1371/journal.pone.0126153

Fig 2. Distribution of IL-10, IL-13, MIP-1β, and TNFα concentrations among male controls (n = 25); male treatment-naïve GD1 patients (GD U; n = 21), and male ERT-treated GD1 patients (GD1ERT; n = 18).

Fig 2

ERT: Imiglucerase, 15–60 U/kg every other week for 3–6 years.